login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VERTEX PHARMACEUTICALS INC (VRTX) Stock News
USA
- NASDAQ:VRTX -
US92532F1003
-
Common Stock
419.1
USD
+2.29 (+0.55%)
Last: 10/20/2025, 8:21:17 PM
419.1
USD
0 (0%)
After Hours:
10/20/2025, 8:21:17 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRTX Latest News, Press Relases and Analysis
All
Press Releases
20 hours ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
6 days ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech
2 days ago - By: The Motley Fool
- Mentions:
ISRG
2 Growth Stocks to Invest $1,000 in Right Now
3 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
4 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
4 days ago - By: The Motley Fool
- Mentions:
CRSP
AAPL
AMZN
GOOG
...
2 Soaring Cathie Wood Stocks to Buy and Hold
7 days ago - By: Benzinga
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
13 days ago - By: Benzinga
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
14 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd
18 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
25 days ago - By: Investor's Business Daily
- Mentions:
XPH
PPH
XBI
IBB
...
Pharma Tariffs Back In Spotlight On New Trump Threat
26 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex Announces Key Advancements Across Kidney Portfolio
a month ago - By: Vertex Pharmaceuticals Incorporated
Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain
a month ago - By: Vertex Pharmaceuticals
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
a month ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
Please enable JavaScript to continue using this application.